Advertisement
Covidien
Subscribe to Covidien
View Sample

FREE Email Newsletter

Covidien Revascularization Device Receives FDA Clearance

March 6, 2012 4:52 am | News | Comments

Covidien, a leading global provider of healthcare products, today announced that the Solitaireâ„¢ FR revascularization device has been cleared by the U.S. Food and Drug Administration. The Solitaire FR device is intended to restore blood flow to the brain in patients suffering acute ischemic stroke by mechanically removing blood clots from blocked vessels.

Covidien Revascularization Device Approved for Interventional Management of Stroke Trial

January 31, 2012 6:01 am | News | Comments

MANSFIELD, Mass.--(BUSINESS WIRE)--Covidien, a leading global provider of healthcare products, today announced that the Solitaireâ„¢ FR Revascularization Device has been approved for investigational use in the Interventional Management of Stroke (IMS III) trial. The Solitaire FR...

Reverse Medical Corporation Announces Sale of its Neurovascular Guide Catheter Business

January 26, 2012 5:58 am | News | Comments

IRVINE, Calif.--(BUSINESS WIRE)--Reverse Medical Corporation today announced that it has sold its line of neurovascular guide catheters to Covidien, a leading global provider of healthcare products. The terms of the transaction were not disclosed. “Despite being a young company...

Advertisement

Covidien CEO Elected Chairman of the Board

January 23, 2012 5:33 am | News | Comments

DUBLIN--(BUSINESS WIRE)--Covidien plc today announced that its Board of Directors has elected President and Chief Executive Officer José E. Almeida to the additional position of Chairman of the Board, effective March 13, 2012. Mr. Almeida will succeed...

Covidien Provides Update on Voluntary Recall of BIS Bilateral Sensors

January 20, 2012 5:10 am | News | Comments

BOULDER, Colo.--(BUSINESS WIRE)--On November 8, 2011, Covidien initiated a voluntary recall of certain lots of its BISâ„¢ Bilateral Sensors, due to a modification which inadvertently reversed the reference and left eye electrode. This modification could potentially cause a change...

Covidien Contraindicates the Use of Duet TRS for Thoracic Surgery, Implements a Voluntary Recall

January 17, 2012 4:49 am | News | Comments

MANSFIELD, Mass.--(BUSINESS WIRE)--Covidien, a leading global provider of healthcare products, today announced that it is conducting a voluntary recall of all production lots for the Duet TRSTM Universal Straight and Articulating Single Use Loading Units...

Covidien Announces CE Mark for Nellcor Respiration Rate Software

December 21, 2011 6:17 am | News | Comments

BOULDER, Colo.--(BUSINESS WIRE)--Covidien, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced it will label the Covidien Nellcorâ„¢ Respiration Rate Version 1.0 Software and...

Covidien's Embolic Protection Device Receives FDA Clearance

December 2, 2011 4:35 am | News | Comments

MANSFIELD, Mass.--(BUSINESS WIRE)--Covidien, a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration (FDA) has cleared SpiderFX® for the treatment of severely calcified lesions used in conjunction with plaque excision...

Advertisement

Covidien Endo Stitch Automated Suturing Device Reduces Hospitalization Costs and Operating Room Time

November 30, 2011 5:22 am | News | Comments

NORTH HAVEN, Conn.--(BUSINESS WIRE)--Covidien, a leading global provider of healthcare products, today announced study data demonstrating that use of its Endo Stitchâ„¢ automated suturing device lowers mean hospital costs and operating room (OR) time during total laparoscopic hysterectomies...

Covidien Patent Enforced Against China-Based Companies

November 23, 2011 6:42 am | News | Comments

NEW HAVEN, Conn.--(BUSINESS WIRE)--Covidien, a leading global provider of healthcare products, today announced that German customs authorities, in cooperation with Covidien, have seized quantities of imported surgical stapling products that copy Covidien's designs and infringe one of its patents.

Covidien Announces Definitive Agreement to Acquire BÂRRX Medical, Inc.

November 22, 2011 6:05 am | News | Comments

DUBLIN--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products and a world leader in advanced energy-based devices, today announced a definitive agreement to acquire BÂRRX Medical, Inc. BÂRRX is the leader in treatment of Barrett's esophagus syndrome...

Covidien Launches World's First Non-Absorbable, Uni-Directional Knotless Suture

October 26, 2011 5:54 am | News | Comments

SAN FRANCISCO--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the launch of the first non-absorbable, uni-directional barbed suture, part of its family of V-Locâ„¢ wound closure devices.

Covidien reports bumps in sales and profit

July 29, 2010 8:37 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Medical device manufacturer Covidien plc has reported its third quarter results, including a 2 percent increase in net sales and net income of $364 million, compared with $281 million in the same quarter in 2009.

Covidien paying $300 million for Somanetics(4)

June 16, 2010 6:13 am | by The Associated Press | News | Comments

Covidien PLC, which makes drugs and medical devices, said Wednesday it is buying its distribution partner Somanetics Corp. for almost $300 million.Covidien is currently the distributor for Somanetics' high-tech diagnostic equipment, called the INVOS Cerebral/Somatic Oximeter, in Europe, the...

Advertisement
X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading